MA38794A1 - New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer - Google Patents
New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancerInfo
- Publication number
- MA38794A1 MA38794A1 MA38794A MA38794A MA38794A1 MA 38794 A1 MA38794 A1 MA 38794A1 MA 38794 A MA38794 A MA 38794A MA 38794 A MA38794 A MA 38794A MA 38794 A1 MA38794 A1 MA 38794A1
- Authority
- MA
- Morocco
- Prior art keywords
- lung cancer
- present
- relates
- large cell
- against multiple
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des peptides, des acides nucléiques et des cellules pour utilisation dans des procédés immunothérapeutiques. En particulier, la présente invention concerne l'immunothérapie du cancer. La présente invention concerne en outre des épitopes peptidiques de lymphocytes t cytotoxiques (ctl), seuls ou en combinaison avec d'autres peptides associés à des tumeurs qui servent de substances pharmaceutiques actives de compositions de vaccin qui stimulent des réponses immunitaires antitumorales. La présente invention concerne plus de 70 nouvelles séquences peptidiques et leurs variants dérivés de molécules hla de classe i et des molécules hla de classe ii de cellules tumorales humaines qui peuvent être utilisées dans des compositions de vaccin pour induire des réponses immunitaires antitumorales.The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to cytotoxic t cell peptide epitopes (ct1), alone or in combination with other tumor-associated peptides that serve as active pharmaceutical substances of vaccine compositions that stimulate antitumor immune responses. The present invention relates to more than 70 novel peptide sequences and variants thereof derived from hla class I molecules and hla class II human tumor cell molecules that can be used in vaccine compositions to induce antitumor immune responses.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1313987.8A GB201313987D0 (en) | 2013-08-05 | 2013-08-05 | Novel immunotherapy against several tumors, such as lung cancer including NSCLC |
| PCT/EP2014/066755 WO2015018805A1 (en) | 2013-08-05 | 2014-08-04 | Novel immunotherapy against several tumors, such as lung cancer, including nsclc |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA38794A1 true MA38794A1 (en) | 2017-12-29 |
| MA38794B1 MA38794B1 (en) | 2019-04-30 |
Family
ID=49224173
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA42333A MA42333A1 (en) | 2013-08-05 | 2014-08-04 | New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer |
| MA46798A MA46798B1 (en) | 2013-08-05 | 2014-08-04 | New immunotherapy against several tumors, such as lung cancer, including large cell lung cancer |
| MA38794A MA38794B1 (en) | 2013-08-05 | 2014-08-04 | New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA42333A MA42333A1 (en) | 2013-08-05 | 2014-08-04 | New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer |
| MA46798A MA46798B1 (en) | 2013-08-05 | 2014-08-04 | New immunotherapy against several tumors, such as lung cancer, including large cell lung cancer |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR113131A2 (en) |
| GB (1) | GB201313987D0 (en) |
| MA (3) | MA42333A1 (en) |
-
2013
- 2013-08-05 GB GBGB1313987.8A patent/GB201313987D0/en not_active Ceased
-
2014
- 2014-08-04 MA MA42333A patent/MA42333A1/en unknown
- 2014-08-04 MA MA46798A patent/MA46798B1/en unknown
- 2014-08-04 MA MA38794A patent/MA38794B1/en unknown
-
2018
- 2018-09-21 AR ARP180102711A patent/AR113131A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA42333A1 (en) | 2019-05-31 |
| MA46798A1 (en) | 2022-02-28 |
| MA38794B1 (en) | 2019-04-30 |
| GB201313987D0 (en) | 2013-09-18 |
| AR113131A2 (en) | 2020-01-29 |
| MA46798B1 (en) | 2022-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39907B1 (en) | New immunotherapy against several tumors, blood, including acute myeloid leukemia (lam) | |
| MA41879A1 (en) | Novel peptides and peptide combination for use in immunotherapy against prostate cancer and other cancers | |
| MA42021A1 (en) | Novel peptides and peptide combination for use in immunotherapy against small cell lung cancer and other cancers | |
| MA40813A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors | |
| MA40794A1 (en) | Novel peptides and combinations of peptides and scaffolds for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers | |
| MA41717A1 (en) | Novel peptides and peptide combination for use in immunotherapy against epithelial ovarian cancer and other cancers | |
| MA42072A1 (en) | Novel peptides and peptide combination for use in immunotherapy against cll and other cancers | |
| MA43719B1 (en) | PEPTIDE FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND SMALL CELL LUNG CANCER | |
| MA41521A1 (en) | Novel cell epitopes and new combination of cell epitopes for use in immunotherapy of myeloma and other cancers | |
| MA42020A1 (en) | Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers | |
| MA43466A1 (en) | Treatments for uterine cancer | |
| MA43075A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against non-Hodgkin lymphoma and other cancers | |
| MA43490A1 (en) | New peptides and combination of peptides for use in immunotherapy against various cancers | |
| MA41237B1 (en) | New peptides and peptide combinations for use in immunotherapy against hepatocellular carcinoma (chc) and other cancers | |
| MA41520B2 (en) | New peptides and peptide combination for use in immunotherapy against ovarian cancer and other cancers | |
| MA41393A1 (en) | Novel peptides and peptide combinations and scaffolds formed therefor for use in immunotherapy against colorectal carcinoma (crc) and other cancers | |
| MA40713A1 (en) | Novel Peptides and Peptide Combination for Use in the Immunotherapy of Pancreatic Cancer and Other Cancers | |
| MA44551A1 (en) | Novel peptides and novel combination of peptides for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers | |
| MA42294B1 (en) | New peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| MA43458A1 (en) | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers | |
| MA49155B1 (en) | New peptides and peptide combination for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers | |
| MA38794A1 (en) | New immunotherapy against multiple tumors, such as lung cancer, including large cell lung cancer | |
| MA42022A1 (en) | Novel peptides, peptide combinations and carriers for use in the immunotherapeutic treatment of various cancers | |
| MA41664A1 (en) | Novel peptides and novel peptide combination for use in immunotherapy, and methods for generating scaffolds for use against pancreatic cancer and other cancers |